Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Thomsen

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Biofilm|January 20, 2023
Hyperbaric oxygen therapy augments ciprofloxacin effect against <i>Pseudomonas aeruginosa</i> biofilm infected chronic wounds in a mouse modelAnne Sofie Laulund, Franziska Angelika Schwartz, Lars Christophersen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 5, 2021
Extensive microbiological respiratory tract specimen characterization in critically ill COVID-19 patientsKim Thomsen, Henrik Planck Pedersen, Susanne Iversen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 12, 2021
Animal models of chronic and recurrent Pseudomonas aeruginosa lung infection: significance of macrolide treatmentKim Thomsen, Osamu Kobayashi, Kenji Kishi, et al.
Journal of Global Antimicrobial Resistance|December 26, 2021
Lactoferricin-inspired peptide AMC-109 augments the effect of ciprofloxacin against Pseudomonas aeruginosa biofilm in chronic murine woundsAnne Sofie Laulund, Franziska Angelika Schwartz, Lars Christophersen, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|February 27, 2013
Pseudomonas aeruginosa biofilm aggravates skin inflammatory response in BALB/c mice in a novel chronic wound modelHannah Trøstrup, Kim Thomsen, Lars J Christophersen, et al.
The Journal of Antimicrobial Chemotherapy|May 7, 2013
Efficacy of a synthetic antimicrobial peptidomimetic versus vancomycin in a Staphylococcus epidermidis device-related murine peritonitis modelJorunn Pauline Cavanagh, Hildegunn Norbakken Granslo, Elizabeth Aarag Fredheim, et al.
Plos One|April 20, 2019
Adjunctive dabigatran therapy improves outcome of experimental left-sided Staphylococcus aureus endocarditisChristian J Lerche, Lars J Christophersen, Jens Peter Goetze, et al.
Frontiers in Microbiology|September 26, 2022
Chicken IgY reduces the risk of <i>Pseudomonas aeruginosa</i> urinary tract infections in a murine modelFranziska A Schwartz, Lars Christophersen, Kim Thomsen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 19, 2020
In vivo demonstration of Pseudomonas aeruginosa biofilms as independent pharmacological microcompartmentsLars Christophersen, Franziska Angelika Schwartz, Christian Johann Lerche, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|November 29, 2023
Risk factors for methicillin-resistant <i>Staphylococcus aureus</i> colonization in a level-IV neonatal intensive care unit: a retrospective studyJulia Elzbieta Galuszka, Kim Thomsen, Jenny Dahl Knudsen, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Biofilm|January 20, 2023
Hyperbaric oxygen therapy augments ciprofloxacin effect against <i>Pseudomonas aeruginosa</i> biofilm infected chronic wounds in a mouse modelAnne Sofie Laulund, Franziska Angelika Schwartz, Lars Christophersen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 5, 2021
Extensive microbiological respiratory tract specimen characterization in critically ill COVID-19 patientsKim Thomsen, Henrik Planck Pedersen, Susanne Iversen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 12, 2021
Animal models of chronic and recurrent Pseudomonas aeruginosa lung infection: significance of macrolide treatmentKim Thomsen, Osamu Kobayashi, Kenji Kishi, et al.
Journal of Global Antimicrobial Resistance|December 26, 2021
Lactoferricin-inspired peptide AMC-109 augments the effect of ciprofloxacin against Pseudomonas aeruginosa biofilm in chronic murine woundsAnne Sofie Laulund, Franziska Angelika Schwartz, Lars Christophersen, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|February 27, 2013
Pseudomonas aeruginosa biofilm aggravates skin inflammatory response in BALB/c mice in a novel chronic wound modelHannah Trøstrup, Kim Thomsen, Lars J Christophersen, et al.
The Journal of Antimicrobial Chemotherapy|May 7, 2013
Efficacy of a synthetic antimicrobial peptidomimetic versus vancomycin in a Staphylococcus epidermidis device-related murine peritonitis modelJorunn Pauline Cavanagh, Hildegunn Norbakken Granslo, Elizabeth Aarag Fredheim, et al.
Plos One|April 20, 2019
Adjunctive dabigatran therapy improves outcome of experimental left-sided Staphylococcus aureus endocarditisChristian J Lerche, Lars J Christophersen, Jens Peter Goetze, et al.
Frontiers in Microbiology|September 26, 2022
Chicken IgY reduces the risk of <i>Pseudomonas aeruginosa</i> urinary tract infections in a murine modelFranziska A Schwartz, Lars Christophersen, Kim Thomsen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 19, 2020
In vivo demonstration of Pseudomonas aeruginosa biofilms as independent pharmacological microcompartmentsLars Christophersen, Franziska Angelika Schwartz, Christian Johann Lerche, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|November 29, 2023
Risk factors for methicillin-resistant <i>Staphylococcus aureus</i> colonization in a level-IV neonatal intensive care unit: a retrospective studyJulia Elzbieta Galuszka, Kim Thomsen, Jenny Dahl Knudsen, et al.
Pageof 4